144 related articles for article (PubMed ID: 1327866)
1. Antiviral nucleoside toxicity in canine bone marrow progenitor cells and its relationship to drug permeation.
Chan TC; Boon GD; Shaffer L; Redmond R
Eur J Haematol; 1992 Aug; 49(2):71-6. PubMed ID: 1327866
[TBL] [Abstract][Full Text] [Related]
2. Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells.
Gallicchio VS; Hughes NK
Life Sci; 1995; 57(18):PL265-73. PubMed ID: 7475901
[TBL] [Abstract][Full Text] [Related]
3. Regulation of megakaryocyte colony forming cell numbers and ploidy by dideoxynucleosides in immunodeficient mice.
Chow FP; Ordóñez JV; Sutton PA; Hamburger AW
Am J Hematol; 1993 Dec; 44(4):249-55. PubMed ID: 8237995
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Ganser A; Greher J; Völkers B; Staszewski S; Hoelzer D
Exp Hematol; 1989 May; 17(4):321-5. PubMed ID: 2540017
[TBL] [Abstract][Full Text] [Related]
5. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
Gallicchio VS; Hughes NK; Tse KF
Int J Immunopharmacol; 1993 Feb; 15(2):263-8. PubMed ID: 8468123
[TBL] [Abstract][Full Text] [Related]
6. Permeation and metabolism of anti-HIV and endogenous nucleosides in human immune effector cells.
Chan TC; Shaffer L; Redmond R; Pennington KL
Biochem Pharmacol; 1993 Jul; 46(2):273-8. PubMed ID: 8347149
[TBL] [Abstract][Full Text] [Related]
7. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages.
Perno CF; Cooney DA; Gao WY; Hao Z; Johns DG; Foli A; Hartman NR; Caliò R; Broder S; Yarchoan R
Blood; 1992 Aug; 80(4):995-1003. PubMed ID: 1379854
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bone marrow myelopoiesis and erythropoiesis in vitro by anti-retroviral nucleoside derivatives.
Johnson M; Caiazzo T; Molina JM; Donahue R; Groopman J
Br J Haematol; 1988 Oct; 70(2):137-41. PubMed ID: 2847772
[TBL] [Abstract][Full Text] [Related]
10. Differential toxicity of carbovir and AZT to human bone marrow hematopoietic progenitor cells in vitro.
Kurtzberg J; Carter SG
Exp Hematol; 1990 Nov; 18(10):1094-6. PubMed ID: 2209763
[TBL] [Abstract][Full Text] [Related]
11. In vitro myelotoxicity of 2',3'-dideoxynucleosides on human hematopoietic progenitor cells.
Du DL; Volpe DA; Grieshaber CK; Murphy MJ
Exp Hematol; 1990 Aug; 18(7):832-6. PubMed ID: 2379548
[TBL] [Abstract][Full Text] [Related]
12. Decreased anti-human immunodeficiency virus type-1 activities of 2',3'-dideoxynucleoside analogs in MOLT-4 cell sublines resistant to 2',3'-dideoxynucleoside analogs.
Cinatl J; Cinatl J; Weber B; Rabenau H; Weissflog A; Mainke M; Kornhuber B; Doerr HW
Acta Virol; 1993 Oct; 37(5):360-8. PubMed ID: 8184788
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV drugs: comparative toxicities in murine fetal liver and bone marrow erythroid progenitor cells.
Gogu SR; Beckman BS; Agrawal KC
Life Sci; 1989; 45(4):iii-vii. PubMed ID: 2761343
[TBL] [Abstract][Full Text] [Related]
14. Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
Dornsife RE; St Clair MH; Huang AT; Panella TJ; Koszalka GW; Burns CL; Averett DR
Antimicrob Agents Chemother; 1991 Feb; 35(2):322-8. PubMed ID: 1708977
[TBL] [Abstract][Full Text] [Related]
15. Selective protection of toxicity of 2',3'-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells.
Faraj A; Schinazi RF; Xie MY; Gosselin G; Perigaud C; Imbach JL; Sommadossi JP
Antiviral Res; 1996 Mar; 29(2-3):261-7. PubMed ID: 8739604
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of anti-HIV nucleosides in microswine.
Swagler AR; Qian MX; Gallo JM
J Pharm Pharmacol; 1991 Dec; 43(12):823-6. PubMed ID: 1687578
[TBL] [Abstract][Full Text] [Related]
17. Reversal of azidothymidine-induced bone marrow suppression by 2',3'-dideoxythymidine as studied by hemopoietic clonal culture.
Yoshida Y; Yoshida C
AIDS Res Hum Retroviruses; 1990 Jul; 6(7):929-32. PubMed ID: 2390336
[TBL] [Abstract][Full Text] [Related]
18. Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.
Shirasaka T; Yarchoan R; O'Brien MC; Husson RN; Anderson BD; Kojima E; Shimada T; Broder S; Mitsuya H
Proc Natl Acad Sci U S A; 1993 Jan; 90(2):562-6. PubMed ID: 8380641
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the in vitro toxicity of 2',3'-dideoxynucleosides to murine hematopoietic progenitor cells.
Du DL; Volpe DA; Grieshaber CK; Murphy MJ
Int J Cell Cloning; 1992 Mar; 10(2):87-93. PubMed ID: 1545153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
